POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
Did Not Advance

West Virginia Legislature establishes a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder

Original title: Establish a regulated framework for the medical use of psilocybin to treat post-traumatic stress disorder (PTSD)

Last action · February 16, 2026: To House Health and Human ResourcesSponsors: Rick Hillenbrand and 2 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

House Bill 5588 adopts the Therapeutic Psilocybin Act, creating a state-regulated medical psilocybin program overseen by the Department of Health to allow the cultivation, testing, recommendation, and administration of psilocybin for qualified patients suffering from post-traumatic stress disorder. The legislation establishes licensing boards, s, electronic verification tracking, and specialized training and registration requirements for medical providers, therapists, and production establishments beginning July 1, 2026.

Why it matters

The measure establishes criminal and civil immunity for registered cultivators, clinicians, and patients participating in the state program, while creating strict security, video surveillance, and testing mandates for all psilocybin facilities and treatment locations.

Background
  • Post-traumatic stress disorder (PTSD) is a severe mental health condition affecting veterans and first responders, often treated with conventional psychotherapies or medications that have high dropout rates. context
  • Psilocybin is a naturally occurring psychedelic compound found in certain fungi that has become the subject of clinical research for its potential in treating treatment-resistant mental health conditions. context

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

Patients with post-traumatic stress disorder

Patients may legally obtain recommendations, possess, and receive supervised administration of medical psilocybin treatment.

Directly affected

Qualified medical psilocybin providers

Medical professionals must complete specific continuing education and department registration to recommend psilocybin treatments.

Directly affected

Psilocybin production establishments

Cultivators and testing laboratories must obtain licenses, post performance bonds, comply with zoning restrictions, and utilize real-time inventory tracking.

Directly affected

State employers and political subdivisions

Employers must provide written notice to employees whose duties involve compliance with the act that their actions may violate federal criminal law.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is eligible to receive medical psilocybin treatment under this act?
Patients who have been recommended treatment by a qualified medical psilocybin provider for qualified medical conditions such as post-traumatic stress disorder and who are at least 21 years old.
Can psilocybin production establishments advertise their products to the general public?
No, psilocybin production establishments are prohibited from advertising to the general public in any medium, except for advertising employment opportunities.
Are employers required to cover medical psilocybin through employee health insurance?
No, insurers, third-party administrators, and employers are not required to pay for or reimburse individuals for psilocybin or psilocybin products.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

4 actions
  1. Feb 16, 2026HouseCommittee
    To House Health and Human Resources
  2. Feb 16, 2026HouseIntroduced
    Introduced in House
  3. Feb 16, 2026HouseCommittee
    To Health and Human Resources
  4. Feb 16, 2026HouseIntroduced
    Filed for introduction

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift99% confidence

Creation of Regulated Psychedelic Framework

The bill shifts state policy from strict criminal prohibition of psilocybin to a tightly regulated medical framework allowing cultivation, testing, and therapeutic administration for PTSD.

Connected Entities

Joint Committee on Government and Finance, West Virginia Department of Homeland Security, Bill Ridenour and 6 more
OrganizationJoint Committee on Government and Finance“Recipient of annual department reports regarding the program”Map →
OrganizationWest Virginia Department of Homeland Security“Consulted for the creation of the electronic verification system”Map →
PersonBill Ridenour“Co-sponsor of House Bill 5588”Map →
PersonEvan Worrell“Co-sponsor of House Bill 5588”Map →
OrganizationFood and Drug Administration“Federal agency approving products exempt or affected by provisions”Map →
OrganizationDepartment of Veterans Affairs“Institution supporting and investing in research on psychedelic-assisted therapi”Map →
OrganizationWest Virginia Department of Agriculture“Consulted for the creation of the electronic verification system”Map →
PersonRick Hillenbrand“Lead sponsor of House Bill 5588”Map →
OrganizationDepartment of Health“State department tasked with overseeing the medical use of psilocybin program”Map →

Sources

Open source document

www.wvlegislature.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 85)
  • Controversy90
    Intensity of disagreement among stakeholders
  • Entertainment15
    Compellingness for a non-policy-wonk reader
  • Buzz75
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record